Showing results (1471-1480 of 1,615) with videos related to
Sort By:
Pageof 162
Human Mutation|August 14, 2020
Expansion of germline RPS20 mutation phenotype to include Diamond-Blackfan anemiaSaleh Bhar, Fujun Zhou, Lucas C Reineke, et al.Journal of Hepatology|August 16, 2022
Head-to-head comparison between MEFIB, MAST, and FAST for detecting stage 2 fibrosis or higher among patients with NAFLDBeom Kyung Kim, Nobuharu Tamaki, Kento Imajo, et al.Gastroenterology|April 10, 2016
Defective Intestinal Mucin-Type O-Glycosylation Causes Spontaneous Colitis-Associated Cancer in MiceKirk Bergstrom, Xiaowei Liu, Yiming Zhao, et al.European Journal of Haematology|August 13, 2023
Outcome of carfilzomib/pomalidomide-based regimens after daratumumab-based treatment in relapsed multiple myeloma: A Canadian Myeloma Research Group Database analysisRichard LeBlanc, Hira Mian, Donna Reece, et al.Journal of Neuroscience Research|May 5, 2021
Sex differences in gut microbiota modulation of aversive conditioning, open field activity, and basolateral amygdala dendritic spine densityCaroline Grace Geary, Victoria Christina Wilk, Katherine Louise Barton, et al.JAMA Network Open|September 29, 2021
Assessment of the Feasibility of Using Noninvasive Wearable Biometric Monitoring Sensors to Detect Influenza and the Common Cold Before Symptom OnsetEmilia Grzesiak, Brinnae Bent, Micah T McClain, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 9, 2019
Immuno-PET Imaging to Assess Target Engagement: Experience from 89Zr-Anti-HER3 mAb (GSK2849330) in Patients with Solid TumorsC Willemien Menke-van der Houven van Oordt, Adam McGeoch, Mats Bergstrom, et al.British Journal of Cancer|November 12, 2009
Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastomaD A Reardon, G Dresemann, S Taillibert, et al.Nature Medicine|January 6, 2026
AI-enabled virtual spatial proteomics from histopathology for interpretable biomarker discovery in lung cancerZhe Li, Yuchen Li, Jinxi Xiang, et al.Clinical Lymphoma, Myeloma & Leukemia|March 28, 2025
Treatment Patterns and Outcomes of Multiple Myeloma Patients Undergoing Second-Line Therapy: A Canadian Myeloma Research Group (CMRG) AnalysisArleigh McCurdy, Engin Gul, Donna Reece, et al.Pageof 162